ADAG (adagene.com) Sof foyda

ADAG (adagene.com) - kompaniyaning tovar belgisi

Adagene (ADAG) tashqi kapitalga bo'lgan bog'liqligini va dastlabki bosqichdagi ishlanmalar noaniqligini qanday bartaraf etishi mumkin? Ushbu grafikdagi kompaniyaning foyda darajalari joriy dinamikani namoyish etadi, bunda -0.02 qiymati joriy ko'rsatkichga mos keladi. SAFE-body platformasining litsenziyalanishi barqarorlikni ta'minlaydi, malakali boshqaruv esa AI antitanachalar dizaynidagi chuqur tajribadan foydalangan holda grantlar orqali xarajatlarni optimallashtiradi.

ADAG (Adagene) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

adagene.com (ADAG) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Adagene Inc.|ADAG - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi ADAG|ADAG - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Adagene|ADAG - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi adagene.com|ADAG - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Adagene|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Adagene Inc.|ADAG - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar ADAG|ADAG - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Adagene|Shoshilinch likvidlik adagene.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ADAG - Sof foyda
Kompaniyaning jamlanma tahlili:Adagene
Adagene Inc asosiy tovari

Ushbu ko'rsatkich barcha operatsion xarajatlar va soliqlardan chegirilgan yakuniy moliyaviy natijani o'lchaydi hamda emitentning erkin pul oqimini yaratish qobiliyatini belgilaydi. Adagene (ADAG) kompaniyasining sof foydasini tahlil qilish bozor shoklariga nisbatan kompaniyaning barqarorligini baholash imkonini beradi, bu esa AI tomonidan ishlab chiqilgan dori vositalarining klinik sinovlari davomida tibbiy ekspertizaning yuqori xarajatlarini hisobga olgan holda juda muhimdir.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR: Sof foyda|Kompaniya foydasi UPB|ZBIO (Zenas Biopharma) - Sof foyda|Sof foyda Immunome Inc|Sof foyda GOSS|KalVista Corp (KALV) - Yillik sof foyda|Sof foyda SEPN (Septerna Inc)|pieris.com (PVLA) - Kompaniyaning sof daromadi|SVRA - Kompaniyaning sof foydasi|RIGL (Rigel Pharma) - Kompaniya foydasi|ANAB: Sof foyda|Kompaniyaning sof daromadi Astria Corp (ATXS)|ENGN (enGene Holdings Inc.) - Sof foyda|Sof foyda rapt.com|Sof foyda JBIO|Aclaris Therapeutics Inc. - Kompaniya foydasi|Sof foyda KYTX (Kyverna)|Sof foyda Tiziana Life Sciences, Ltd. TLSA|Cabaletta Bio, Inc. - Sof foyda|Yillik sof foyda ventyxbio.com (VTYX)|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Sof foyda|AGEN: Yakuniy foyda|Sof foyda CLYM|Sof foyda zurabio.com (ZURA)|Kompaniyaning sof foydasi aTyr Pharma ATYR|Yakuniy foyda IMA|STTK - Kompaniyaning sof foydasi|Equillium, Inc. (EQ) - Sof daromad|CNTB: Sof foyda|Immunic (IMUX) - Sof foyda|Sof daromad ATRA|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Kompaniyaning sof foydasi Celularity CELU|INMB - Sof daromad|BRNS - Kompaniyaning sof foydasi|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS (SAB Biotherapeutics, Inc) - Sof daromad|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Kompaniya foydasi QTTB (Q32 Bio Corp)|Sof foyda GOVX|EDSA - Kompaniyaning sof daromadi|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals - Sof foyda|BOLT (Bolt Biotherapeutics) - Kompaniya foydasi|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|AIM (AIM ImmunoTech) - Sof foyda|ADTX - Yillik sof foyda|Sof foyda GRI|XRTX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB: Kompaniya foydasi|Indaptus - Sof foyda|Kompaniyaning sof daromadi BiondVax Pharmaceuticals|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|ALLK (Allakos Inc) - Sof foyda|Kompaniya foydasi HOOK (HOOKIPA)|Sof foyda IGMS|Sof foyda iTeos Pharma (ITOS)|Sof foyda OCEA (Ocean Biomedical, Inc.)|Yillik sof foyda tcbiopharm.com|THRD - Kompaniyaning sof foydasi